Cullinan Therapeutics, Inc. (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

12.74

-0.34 (-2.60%)

At close: Mar 20, 2026, 4:00 PM EDT

12.46

-0.28 (-2.20%)

Pre-market: Mar 23, 2026, 5:12 AM EDT

Cullinan Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	88.33	83.01	98.43	156.15	59.77
Short-Term Investments	289.56	315.97	368.63	311.14	230.69
Cash & Short-Term Investments	377.9	398.98	467.07	467.29	290.47
Cash Growth	-5.28%	-14.58%	-0.05%	60.88%	38.18%
Other Current Assets	8.86	15.69	13.12	7.18	6.1
Total Current Assets	386.76	414.67	480.19	474.47	296.56
Net Property, Plant & Equipment	3.05	2.35	3.53	5.3	0.08
Long-Term Investments	58.27	204.44	-	80.88	140.4
Other Long-Term Assets	0.3	0.37	0.46	0.46	0.15
Total Assets	448.37	621.82	484.18	561.12	437.19
Accounts Payable	0.84	1.68	2.49	2.66	3.17
Accrued Expenses	36.12	27.66	24.2	14.14	8.58
Current Portion of Leases	0.78	1.3	1.44	1.42	-
Other Current Liabilities	-	-	-	4.28	-
Total Current Liabilities	37.74	30.65	28.14	22.5	11.75
Long-Term Leases	1.9	0.85	2.15	3.59	-
Other Long-Term Liabilities	-	-	-	-	0.07
Total Long-Term Liabilities	1.9	0.85	2.15	3.59	0.07
Total Liabilities	39.64	31.5	30.29	26.09	11.81
Common Stock	0.01	0.01	0	0.01	0
Additional Paid-in Capital	995.82	958.7	654.69	585.32	584.71
Accumulated Other Comprehensive Income	1.02	-0.13	-0.13	-2.6	-0.84
Retained Earnings	-588.12	-368.24	-200.86	-47.7	-158.91
Total Common Shareholders' Equity	408.73	590.33	453.7	535.03	424.97
Minority Interest	-	-	0.19	-	0.4
Shareholders' Equity	408.73	590.33	453.9	535.03	425.37
Total Liabilities & Equity	448.37	621.82	484.18	561.12	437.19
Total Debt	2.68	2.15	3.59	5.01	0
Net Cash (Debt)	375.21	396.83	463.48	462.28	290.47
Net Cash Growth	-5.45%	-14.38%	0.26%	59.15%	38.18%
Net Cash Per Share	6.35	7.38	-	9.91	6.74
Book Value	408.73	590.33	453.7	535.03	424.97
Book Value Per Share	6.92	10.98	-	11.47	9.87
Tangible Book Value	408.73	590.33	453.7	535.03	424.97
Tangible Book Value Per Share	6.92	10.98	-	11.47	9.87

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q